STAAR Surgical Company
STAA
$27.97
$0.010.04%
NASDAQ
| 06/27/2025 | 03/28/2025 | 12/27/2024 | 09/27/2024 | 06/28/2024 | |
|---|---|---|---|---|---|
| Net Income | -327.84% | -1,523.57% | -541.31% | 107.18% | 21.69% |
| Total Depreciation and Amortization | 29.76% | 88.92% | 95.96% | 30.83% | 5.04% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -70.71% | 140.44% | 171.32% | 6.36% | 4.39% |
| Change in Net Operating Assets | 49.00% | 74.80% | 25.07% | 16.42% | -23.85% |
| Cash from Operations | -161.68% | -126.45% | -97.99% | 163.87% | -65.13% |
| Capital Expenditure | 71.26% | 71.78% | -85.40% | 32.16% | -106.90% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 286.47% | 72.14% | -154.02% | -170.71% | -209.45% |
| Cash from Investing | 221.54% | 118.39% | -187.02% | -210.68% | -303.19% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 100.00% | -5.00% | -2.50% | -7.69% | -5.00% |
| Issuance of Common Stock | -96.77% | -92.92% | -90.20% | -77.17% | -74.81% |
| Repurchase of Common Stock | -2,625.75% | -4.39% | -10,800.00% | 100.00% | -23.70% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -2,885.28% | -123.37% | -129.97% | -77.28% | -87.48% |
| Foreign Exchange rate Adjustments | 307.88% | 130.52% | -201.50% | 541.28% | 25.17% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 80.85% | -29.35% | -135.69% | -187.89% | -761.05% |